NCT07434323Completed
Lavender Aromatherapy for Preoperative Anxiety in Melanoma and Epithelioma Patients
Benefits of Lavender Essential Oil Aromatherapy in the Management of Preoperative Anxiety in Patients Undergoing Surgical Excision of Melanoma or Epithelioma: A Prospective Randomized Study
Source: ClinicalTrials.gov · Last updated 25 Feb 2026
Brief summary (registry, in English)
This double-blind, randomized, placebo-controlled trial evaluates whether a single 15-minute session of inhalational lavender aromatherapy, administered preoperatively, reduces anxiety in adult patients (ASA I-II) scheduled for surgical radicalization of pT1a melanoma or epithelioma. Physiological parameters (blood pressure, heart rate, respiratory rate) and validated psychometric scales (DASS-21, STAI Y-1 and Y-2) will be recorded at defined time points before and after the intervention. Total planned enrollment: 66 participants
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 66 (actual)
- First submitted
- 3 Feb 2026
- Start date
- 2 Nov 2021
- Primary completion date
- 16 Dec 2021
- Lead sponsor
- San Gallicano Dermatological Institute IRCCS
- Diseases
- Melanoma
- NCT number
- NCT07434323
What you commit to
- Study type: Interventional
- Participants enrolled: 66
- From 2 Nov 2021 to the primary completion date, 16 Dec 2021
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of anxiolytic, antidepressant, or psychotropic medications
Other illness
- Known allergy or hypersensitivity to lavender or essential oils
- History of psychiatric disorders or ongoing psychological treatment
- Cognitive impairment or inability to complete questionnaires independently
- Severe respiratory diseases (e.g., asthma, COPD) that could interfere with inhalational aromatherapy
Other
- Pregnancy or breastfeeding
- ASA physical status classification ≥ III
- Participation in another interventional clinical trial at the same time
Who the study is looking for
- Adults aged 18 to 80 years
- Patients diagnosed with pT1a melanoma or non-melanoma skin cancer (epithelioma)
- Scheduled for surgical radicalization under local anesthesia
- American Society of Anesthesiologists (ASA) physical status classification I or II
- Ability to understand and complete self-administered questionnaires (STAI Y-1, STAI Y-2, DASS-21)
- Willingness and ability to provide written informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| San Gallicano Dermatological Institute IRCCS Coordinator of this site? Confirm its status | Roma | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.